Pintas & Mullins Law Firm

Blog Posts in 2009

  • FDA Warnings against Simultaneous Use of Plavix and Prilosec or Nexium

    Millions of Americans take the blood thinner Plavix to reduce their risk of blood clots, which may lead to heart attack or stroke. Since Plavix can lead to an upset stomach, doctors often prescribe Prilosec and Nexium to treat this symptom. However, the FDA recently issued warnings that these medications may decrease the anti-clotting benefits by Plavix by almost half. This can be very dangerous, ...
    Continue Reading
  • Accutane and Increased Risk of Inflammatory Bowel Disease

    In June of this year, Roche Holding quietly pulled the drug Accutane from the market. Accutane is prescribed to treat moderate to severe cases of acne. The drug has had an extensive history of leading to adverse effects since its approval in 1982, such as suicidal behavior and birth defects. The removal of the drug from the market came in the face of increasing proof that Accutane leads to another ...
    Continue Reading
  • Federal Investigation into Marketing Practices of Depakote

    The Chicago Tribune recently reported that Abbott Laboratories is under investigation for their sale and marketing practices of Depakote. Depakote is prescribed primarily to treat bipolar disorder. In certain cases, it is also used to treat major depressive disorder, epilepsy, chronic pain associated with neuropathy, and migraine headaches. The federal probe was initiated to find out if Abbott ...
    Continue Reading
  • Zicam Shareholder Lawsuit

    On Thursday of last week, a federal appeals court unanimously voted to reinstate a shareholder lawsuit against Matrixx Initiatives, the makers of the popular cold remedy Zicam. The lawsuit claims that the shareholders of the company did not disclose information that the drug was potentially harmful to the public and instead issued incorrect and misleading statements. Judge Tashima, a part of the ...
    Continue Reading
  • Taking Aranesp Increases Your Risk of Suffering a Stroke

    A new study published last week pointed to an increased risk of stroke for patients taking the medication Aranesp. Aranesp is part of a class of drugs known as erythropoiesis-stimulating agents (ESAs), which stimulate the body to produce more red blood cells. ESAs are primarily used to treat anemia in patients with chronic kidney failure, cancer patients who became anemic through chemotherapy, and ...
    Continue Reading
Page of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.